Close Menu

NEW YORK (GenomeWeb) – Danaher today initiated its 2018 outlook, saying earnings per share is anticipated to be in the range of $3.50 to $3.60.

On an adjusted basis, EPS was guided to a range of $4.25 to $4.35, which assumes revenue growth of between 3.5 percent and 4 percent, the company said. The consensus Wall Street estimate for 2018 is for EPS of $4.34.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.